PD18-07 A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION
Notice bibliographique
Résumé
You have accessJournal of UrologyBladder Cancer: Non-invasive II (PD18)1 Apr 2019PD18-07 A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION Thomas Hermanns*, Andrea J. Savio, Ekaterina Olkhov-Mitsel, Andrea Mari, Karim Saba, Bimal Bhindi, Bethany Gill, Jenna Sykes, Cynthia Kuk, Cedric Poyet, Peter J. Wild, Aidan Noon, Shaheena Bashir, Tristan Juvet, Ricardo A. Rendon, David Waltregny, Theodorus van der Kwast, Antonio Finelli, Girish S. Kulkarni, Neil E. Fleshner, Kirk Lo, Bharati Bapat, and Alexandre R. Zlotta Thomas Hermanns*Thomas Hermanns* More articles by this author , Andrea J. SavioAndrea J. Savio More articles by this author , Ekaterina Olkhov-MitselEkaterina Olkhov-Mitsel More articles by this author , Andrea MariAndrea Mari More articles by this author , Karim SabaKarim Saba More articles by this author , Bimal BhindiBimal Bhindi More articles by this author , Bethany GillBethany Gill More articles by this author , Jenna SykesJenna Sykes More articles by this author , Cynthia KukCynthia Kuk More articles by this author , Cedric PoyetCedric Poyet More articles by this author , Peter J. WildPeter J. Wild More articles by this author , Aidan NoonAidan Noon More articles by this author , Shaheena BashirShaheena Bashir More articles by this author , Tristan JuvetTristan Juvet More articles by this author , Ricardo A. RendonRicardo A. Rendon More articles by this author , David WaltregnyDavid Waltregny More articles by this author , Theodorus van der KwastTheodorus van der Kwast More articles by this author , Antonio FinelliAntonio Finelli More articles by this author , Girish S. KulkarniGirish S. Kulkarni More articles by this author , Neil E. FleshnerNeil E. Fleshner More articles by this author , Kirk LoKirk Lo More articles by this author , Bharati BapatBharati Bapat More articles by this author , and Alexandre R. ZlottaAlexandre R. Zlotta More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555579.23708.62AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Aberrant DNA methylation is very common in bladder cancer (BC) pathogenesis and progression. These epigenetic alterations are detectable in voided urine and might be useful as non-invasive urinary biomarkers for the early detection of BC. We aimed to assess whether a panel of previously identified differentially methylated genes can be used as diagnostic urine assay to predict the presence of BC and discriminate between low-grade (LG) and high-grade (HG) disease. METHODS: Urinary DNA was extracted from voided urine of 313 patients with LG or HG BC and BC-free controls in 4 different centers (Toronto (2) and Halifax, CA and Zurich, CH). Methylation status of urinary cell sediment DNA was evaluated using qPCR-based MethyLight assay for 5 different genes (TWIST1, RUNX3, GATA4, NID2, FOXE1). These genes were previously identified to be differentially methylated in LG and HG BC using two different genome-wide methylation-profiling platforms. Multivariable logistic regression prediction models were created. RESULTS: There were 211 bladder cancer patients (180 non-muscle invasive) and 102 controls. In univariate analyses, all methylation biomarkers were statistically significant predictors of cancer vs. no cancer (all p-values <0.01), and HG vs. LG-BC (all p-values<0.01). In multivariable analysis, NID2, TWIST1 and age were independent predictors of BC (all p<0.05). Multivariable models predicting BC overall and discriminating between high-grade and low-grade bladder cancer reached AUCs of 0.89 and 0.78, respectively. CONCLUSIONS: Our multi-centric study supports the promise of epigenetic urinary markers in non-invasively detecting bladder cancer and discriminating between grades. Validation in different clinical settings including patients with hematuria, bladder cancer surveillance or screening in high-risk populations is warranted to support its utility. Source of Funding: Canadian Urological Association / Astellas Research Grant Program Zurich, Switzerland; Toronto, Canada; Florence, Italy; Zurich, Switzerland; Toronto, Canada; Zurich, Switzerland; Toronto, Canada; Halifax, Canada; Liege, Belgium; Toronto, Canada© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e313-e314 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Thomas Hermanns* More articles by this author Andrea J. Savio More articles by this author Ekaterina Olkhov-Mitsel More articles by this author Andrea Mari More articles by this author Karim Saba More articles by this author Bimal Bhindi More articles by this author Bethany Gill More articles by this author Jenna Sykes More articles by this author Cynthia Kuk More articles by this author Cedric Poyet More articles by this author Peter J. Wild More articles by this author Aidan Noon More articles by this author Shaheena Bashir More articles by this author Tristan Juvet More articles by this author Ricardo A. Rendon More articles by this author David Waltregny More articles by this author Theodorus van der Kwast More articles by this author Antonio Finelli More articles by this author Girish S. Kulkarni More articles by this author Neil E. Fleshner More articles by this author Kirk Lo More articles by this author Bharati Bapat More articles by this author Alexandre R. Zlotta More articles by this author Expand All Advertisement PDF downloadLoading ...
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,001 | 0,004 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,002 | 0,001 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,002 | 0,001 |
| Science ouverte | 0,001 | 0,001 |
| Intégrité de la recherche | 0,001 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,020 | 0,009 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».